OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+0.58%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$602M
AUM Growth
+$602M
(-12%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
63
New
5
Increased
16
Reduced
14
Closed
15
Top Buys
| 1 |
Kiniksa Pharmaceuticals
KNSA
|
$11.6M |
| 2 |
Larimar Therapeutics
LRMR
|
$7.15M |
| 3 |
GeneDx Holdings
WGS
|
$5.24M |
| 4 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$4.26M |
| 5 |
Keros Therapeutics
KROS
|
$3.29M |
Top Sells
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$12.1M |
| 2 |
Disc Medicine
IRON
|
$11M |
| 3 |
CKPT
Checkpoint Therapeutics
CKPT
|
$9.19M |
| 4 |
Immunovant
IMVT
|
$7.49M |
| 5 |
Sanara MedTech
SMTI
|
$7.01M |
Sector Composition
| 1 | Healthcare | 97.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ocular Therapeutix
OCUL
$2.12B
| $91.9M | 15.26% | 6,480,000 | – | – |
|
|
CMRX
2
DELISTED
Chimerix, Inc.
CMRX
| $37M | 6.15% | 4,630,000 +140,000 | +3% | +$1.12M |
|
3
Celldex Therapeutics
CLDX
$1.47B
| $32.9M | 5.47% | 985,000 | – | – |
|
4
BridgeBio Pharma
BBIO
$9.89B
| $31.5M | 5.24% | 517,150 -66,617 | -11% | -$4.06M |
|
5
Codexis
CDXS
$246M
| $30.5M | 5.06% | 1,345,000 -55,000 | -4% | -$1.25M |
|
6
Eton Pharmaceutcials
ETON
$464M
| $29.3M | 4.87% | 3,692,600 -347,400 | -9% | -$2.76M |
|
7
Harrow
HROW
$1.44B
| $29.2M | 4.85% | 3,140,000 +74,584 | +2% | +$693K |
|
8
Protara Therapeutics
TARA
$120M
| $24.9M | 4.14% | 2,558,472 | – | – |
|
9
Stereotaxis
STXS
$261M
| $24.4M | 4.05% | 2,526,500 | – | – |
|
|
TCON
10
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $16.3M | 2.71% | 2,518,371 | – | – |
|
|
11
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $16.1M | 2.67% | 1,155,200 +834,274 | +260% | +$11.6M |
|
12
MacroGenics
MGNX
$112M
| $15.5M | 2.58% | 578,150 -88,050 | -13% | -$2.37M |
|
13
Protagonist Therapeutics
PTGX
$3.67B
| $14.8M | 2.46% | 330,222 +33,222 | +11% | +$1.49M |
|
14
Fortress Biotech
FBIO
$76.8M
| $13.8M | 2.3% | 3,875,000 | – | – |
|
15
Xoma
XOMA
$392M
| $11.7M | 1.94% | 343,600 -93,900 | -21% | -$3.19M |
|
16
Cytokinetics
CYTK
$4.23B
| $11.5M | 1.91% | 580,000 | – | – |
|
17
Neurogene
NGNE
$264M
| $10.7M | 1.77% | 1,156,200 -68,800 | -6% | -$635K |
|
|
AFIB
18
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $10.2M | 1.69% | 599,990 -15,000 | -2% | -$255K |
|
|
19
Keros Therapeutics
KROS
$618M
| $9.98M | 1.66% | 235,000 +77,500 | +49% | +$3.29M |
|
20
Verastem
VSTM
$569M
| $9.46M | 1.57% | 2,325,000 | – | – |
|
21
ProQR Therapeutics
PRQR
$237M
| $9.3M | 1.55% | 1,380,400 +77,400 | +6% | +$522K |
|
22
Sutro Biopharma
STRO
$72.7M
| $9.24M | 1.53% | 496,900 +154,950 | +45% | +$2.88M |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $8.82M | 1.47% | 1,670,600 | – | – |
|
24
ESSA Pharma
EPIX
$11.4M
| $8.12M | 1.35% | 284,050 | – | – |
|
25
Vaxcyte
PCVX
$4B
| $8.05M | 1.34% | 357,800 | – | – |
|